CClinicalTrials.gg
Not yet recruitingNCT07518680Updated Apr 8, 2026

A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery

An interventional study of Pressing the Tiantu acupoint to stimulate coughing in Esophageal Neoplasms, sponsored by Shanghai Zhongshan Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by Shanghai Zhongshan Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study is a single-center, self-controlled trial. Patients will successively undergo voluntary coughing without intervention, a washout period, coughing stimulated by pressing the Tiantu acupoint, a washout period, and voluntary coughing without intervention. Vital signs of the patients before and after each cough will be recorded, as well as the changes in peak cough flow rate and intra-abdominal pressure after each cough. For peak cough flow rate and intra-abdominal pressure, three sets of data will be collected each time, and the best value will be taken. This pilot trial is conducted to verify the feasibility of the research design and to provide sample size estimation and data support for the main study.

Read the detailed description

This study is a single-center, self-controlled trial. Patients will successively undergo voluntary coughing without intervention, a washout period, coughing stimulated by pressing the Tiantu acupoint, another washout period, and voluntary coughing without intervention. Vital signs of the patients before and after each cough will be recorded, as well as the changes in peak cough flow rate and intra-abdominal pressure after each cough. Three sets of data will be collected for peak cough flow rate and intra-abdominal pressure each time, and the best value will be taken. The force, angle, and method of pressing are all specified with specific values. The finger pressure is measured by a pressure gauge at 1.59 to 3.45 N, each press lasts for 4 seconds, with an interval of 5 minutes, and is repeated three times. This pilot trial is conducted to verify the feasibility of the research design and provide sample size estimation and data support for the main study. It mainly focuses on patients after esophageal surgery to investigate whether pressing the Tiantu acupoint can effectively improve the coughing ability of patients.

02

Conditions studied

  • Esophageal Neoplasms
03

In context

Esophageal Neoplasms

1,593 studies on the registry are indexed under Esophageal Neoplasms; 461 are open to participants now.

This study's planned enrollment of 30 is below the median of 58 across 1,171 interventional studies indexed under Esophageal Neoplasms.

Browse Esophageal Neoplasms studies →

Lead sponsor

Shanghai Zhongshan Hospital is the lead sponsor of 636 studies on the registry; 283 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Voluntarily sign the informed consent form and follow the requirements of the protocol;
  2. Age 18 to 75 years old (inclusive), gender not limited;
  3. Patients who have undergone esophageal surgery (without intubation);
  4. Not taking psychotropic drugs, mentally sound, and likely to cooperate in completing the assessment and intervention.

Exclusion criteria

Exclusion Criteria:

  1. The subjects or their family members request to withdraw from the study;
  2. Pregnancy or lactation period;
  3. Severe heart and lung diseases (such as heart failure, acute exacerbation of COPD, asthma, etc.);
  4. Skin damage or infection in the area of the Tiantu acupoint;
  5. Within the last month, have received other cough-related interventions (such as acupuncture, physical therapy);
  6. Other situations that the researcher deems unsuitable for participating in this clinical trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Pressing the Tiantu acupoint to stimulate coughing

    At the end of the patient's inhalation, trained and qualified personnel with qualifications perform the compression. The right thumb or middle and index fingers are flexed and use the tips of the fingers to press on the patient's thyroid cartilage point (the thyroid cartilage point is located on the anterior midline of the neck, in the center of the supra-sternal fossa). Press vertically inward, with the tips of the fingers touching each other closely, aiming to cause itching in the throat. Stimulate the trachea to trigger a cough. The force should be at the minimum level that can produce a cough reflex. The pressure of the fingers is measured using a pressure gauge, which is 1.59 to 3.45 N. Each compression lasts for 4 seconds, with an interval of 5 minutes. Repeat this process 3 times (select the best value).

    Other: Pressing the Tiantu acupoint to stimulate coughing

Interventions

  • OtherPressing the Tiantu acupoint to stimulate coughing

    At the end of inhalation, press the Tiantu acupoint to stimulate coughing. The specific operation method has been mentioned earlier.

06

What researchers measure

Primary outcomes

  1. Cough peak expiratory flow rate at each time point

    The maximum expiratory flow rate generated in the airway when coughing forcefully and rapidly. Measured by a portable peak flow meter sealed at the patient's mouth during coughing. It is a crucial and objective quantitative indicator for evaluating cough efficiency and the strength of the expiratory muscles.

    Time frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation

Secondary outcomes

  1. Change in intra-abdominal pressure at each time point

    The change in intra-abdominal pressure is the key driving force for effective coughing and can be used to assess the strength of the cough. Measured by bladder manometry, the baseline value before coughing and the peak value during coughing are recorded, and the difference is calculated to assess cough strength.

    Time frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation

  2. Oxygen saturation at each time point

    Oxygen saturation (SpO2) recorded from the bedside patient monitor. It can indirectly assess the effectiveness of the patient's coughing after Tiantu acupoint stimulation.

    Time frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation

  3. Blood pressure at each time point

    Blood pressure recorded from the bedside patient monitor. Used to assess the safety of Tiantu acupoint stimulation by comparing hemodynamic fluctuations between stimulated and unstimulated coughing.

    Time frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation

  4. Heart rate at each time point

    Heart rate recorded from the bedside patient monitor. Used to assess the safety of Tiantu acupoint stimulation by comparing heart rate fluctuations between stimulated and unstimulated coughing.

    Time frame: Baseline, during acupoint stimulation, and 30 minutes post-stimulation

07

Study locations

1 site
  • Zhongshan Hospital
    Shanghai, Shanghai Municipality 200032, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07518680
Lead sponsor
Shanghai Zhongshan Hospital
Responsible party
Sponsor
First posted
Apr 8, 2026
Start date
Apr 10, 2026 (estimated)
Primary completion
May 10, 2026 (estimated)
Completion
May 31, 2026 (estimated)
Last update
Apr 8, 2026

Study contacts

Minjie Ju, ScD
Contact
2943045720@qq.com
19180861785
Minjie Ju, ScD
study director · Shanghai Zhongshan Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion